pegaspargase
| Brand name | Oncaspar |
|---|---|
| Active ingredient | pegaspargase |
| Strength | 3,750IU/5ML(750IU/ML) |
| Dosage form | Injection |
| Route | Intravenous, Intramuscular |
| Modality | Biologic |
| FDA approval | February 1994 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.